RET/TRKA-IN-1
RET/TRKA-IN-1 (Compound 13) is a dual inhibitor for RET (IC50=0.375 µM) and TRKA. RET/TRKA-IN-1 inhibits cell viability of LC-2 and KM12, with GI50 of 0.72 and 0.25 μM. RET/TRKA-IN-1 arrests the cell cycle at G1 phase[1].
Product Specifications
CAS Number
[3048634-52-9]
UNSPSC
12352005
Target
RET; Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-trka-in-1.html
Smiles
CN1N=CC(C2=CC=C(C3=C(NC4=CC=C(CC(NC5=CC(C(C)(C)C)=NN5C)=O)C=C4)N=CN=C3N6)C6=C2)=C1
Molecular Formula
C30H31N9O
Molecular Weight
533.63
References & Citations
[1]Acharya B, et al., Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors. Bioorg Med Chem. 2024 May 15;106:117749.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Sinorhizobium medicae Ribosome maturation factor RimP (rimP)
Recombinant Sinorhizobium medicae Ribosome maturation factor RimP (rimP)
Recombinant Sinorhizobium medicae Ribosome maturation factor RimP (rimP)
Recombinant Sinorhizobium medicae Ribosome maturation factor RimP (rimP)
Recombinant Sinorhizobium medicae Ribosome maturation factor RimP (rimP)